| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Incorporated (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 26 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 133.5K | $62.31M | - | |
| COO | 63.4K | $29.58M | - | |
| VP | 51.1K | $23.84M | - | |
| VP | 42.3K | $19.74M | - | |
| Other | 24.0K | $11.22M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Bozic Carmen53 | EVP And CMO | Sell | 4,062 | $450.00 | $1,827,900.00 | -19.3% | - | - | |
| May 29, 2026 | Bozic Carmen53 | EVP And CMO | Sell | 1,974 | $450.00 | $888,300.00 | -8.0% | - | - | |
| Jan 7, 2026 | Tatsis Ourania48 | EVP, Chief Reg. &Quality Off. | Sell | 4,500 | $474.99 | $2,137,455.00 | -9.6% | -10.8% | - | |
| Jan 6, 2026 | Wagner Charles F Jr50 | EVP, Co &Fo | Sale+OE | 9,532 | $461.00 | $4,394,252.00 | -20.2% | -7.3% | - | |
| Dec 3, 2025 | Leiden Jeffrey M47 | Executive Chairman | Sale+OE | 63,781 | $449.20 | $28,650,336.65 | -8.2% | +2.4% | - | |
| Dec 3, 2025 | Wagner Charles F Jr50 | EVP, Co &Fo | Sell | 14,000 | $456.00 | $6,384,000.00 | -14.5% | +2.4% | - | |
| Dec 3, 2025 | Biller Jonathan46 | EVP And Chief Legal Officer | Sell | 347 | $449.00 | $155,803.00 | -2.2% | +2.4% | - | |
| Dec 3, 2025 | Tatsis Ourania48 | EVP, Chief Reg. &Quality Off. | Sell | 4,500 | $449.99 | $2,024,955.00 | -8.8% | +2.4% | - | |
| Nov 17, 2025 | Atkinson Edward Morrow III49 | EVP, Chief Technical Ops. Off. | Sell | 2,500 | $434.58 | $1,086,450.00 | -12.9% | +10.0% | - | |
| Nov 14, 2025 | Leiden Jeffrey M47 | Executive Chairman | Sale+OE | 73,292 | $440.60 | $32,292,319.86 | -33.9% | +6.4% | - |